Abstract:Chromosomal insertion-derived BCR–ABL1 fusion is rare and mostly cryptic in chronic myeloid leukemia (CML). Most of these cases present a normal karyotype, and their risk and/or prognostic category are uncertain. We searched our database and identified 41 CML patients (20 M/21 F, median age: 47 years, range 12–78 years) with insertion-derived BCR–ABL1 confirmed by various FISH techniques: 31 in chronic phase, 1 in accelerated phase, and 9 in blast phase at time of diagnosis. Conventional cytogenetics analysis showed a normal karyotype (n = 19); abnormal karyotype with morphologically normal chromosomes 9 and 22 (n = 5); apparent ins(9;22) (n = 2) and abnormal karyotype with apparent abnormal chromosomes 9, der(9) and/or 22, der(22) (n = 15). The locations of insertion-derived BCR–ABL1 were identified on chromosome 22 (68.3%), 9 (29.3%), and 19 (2.4%). Complex chromosomal abnormalities were often overlooked by conventional cytogenetics but identified by FISH tests in many cases. After a median follow-up of 58 months (range 1–242 months), 11 patients died, and 3 lost contact, while the others achieved different cytogenetic/molecular responses. The locations of BCR–ABL1 (der(22) vs. non-der(22)) and the karyotype results (complex karyotype vs. noncomplex karyotype) by conventional cytogenetics were not associated with overall survival in this cohort. However, redefining the complexity of chromosomal abnormality by correlating karyotype and FISH findings, CML cases with simple chromosomal abnormalities had a more favorable overall survival than that with complex chromosomal abnormalities. We conclude that insertion-derived BCR–ABL1 fusions often involve complex chromosomal abnormalities which are overlooked by conventional cytogenetics, but can be identified by one or more FISH tests. We also suggest that the traditional cytogenetic response criteria may not apply in these patients, and the complexity of chromosomal abnormalities redefined by correlating karyotype and FISH findings can plays a role in stratifying patients into more suitable risk groups for predicting prognosis. (Word count: 292)

Clonal Evolution of AML1-ETO Coexisting with BCR-ABL and Additional Chromosome Abnormalities in a Blastic Transformation of Chronic Myeloid Leukemia

Extramedullary blast crisis of CD 34 + CD 38-leukemia stem cells in chronic myeloid leukemia resistant to tyrosine kinase inhibitors : a report of two cases

[Cytogenetic and Molecular Analysis of 1193 Cases with Chronic Myeloid Leukemia].

Cytogenetic profile of 1,863 Ph/BCR-ABL-positive chronic myelogenous leukemia patients from the Chinese population

Detection of FLT3/ITD, JAK2(V617F) and NPM1 gene mutations in chronic myelomonocytic leukemia

Bilineal Extramedullary Blast Crisis As an Initial Presentation of Chronic Myeloid Leukemia: A Case Report and Literature Review

Sudden Extramedullary Blast Crisis of Chronic Myeloid Leukemia Manifesting As T-cell Lymphoblastic Lymphoma.

Extramedullary T-Lymphoblastic Blast Crisis in Chronic Myelogenous Leukemia: A Case Report of Successful Diagnosis and Treatment

Sudden Extramedullary and Extranodal Philadelphia-positive Anaplastic Large-Cell Lymphoma Transformation During Imatinib Treatment for CML: A Case Report

Deciphering Potential Molecular Signatures to Differentiate Acute Myeloid Leukemia (AML) with BCR::ABL1 from Chronic Myeloid Leukemia (CML) in Blast Crisis

Comprehensive molecular characterization of a rare case of Philadelphia chromosome-positive acute myeloid leukemia

Chronic Myeloid Leukemia Unveils Its Dark Side: A Rare Case of Megakaryocytic Blast Crisis

Clonal Evolution Analyses of a Chronic Myeloid Leukemia Patient with Hematopoietic Stem Cell Transplantation Based on Deep Sequencing

[Evolvement of a Five-Way Translocation T(5;9;22;6;17) from a Four-Way Philadelphia Translocation T(5;9;22;6) in a Rare Case of Chronic Myeloid Leukemia].

The morphological, immunophenotypical and cytogenetic characteristics study of blast crisis in chronic myeloid leukemia]

Chromosomal Aberrations During Progression of Chronic Myeloid Leukemia Identified by Cytogenetic and Molecular Cytogenetic Tools: Implication of 1Q12-21.

Chronic myeloid leukemia with two rare fusion gene transcripts of atypical BCR::ABL: A case report and literature review

Blast Transformation of Chronic Myeloid Leukemia Driven by Acquisition of t(8;21)(q22;q22)/RUNX1::RUNX1T1: Selecting Optimal Treatment Based on Clinical and Molecular Findings

A Rare Case of X-Linked Four-Way Philadelphia Chromosome Translocation with Therapeutic Challenges and Clonal Evolution

Chromosome and Bcr Rearrangement in Chronic Myelogenous Leukaemia and Their Correlation with Clinical States and Prognosis of the Disease

Correction: Chronic Myeloid Leukemia with Insertion-Derived BCR–ABL1 Fusion: Redefining Complex Chromosomal Abnormalities by Correlation of FISH and Karyotype Predicts Prognosis